A study from Bahrain identified two deleterious mutations, BRCA1 c.4850C>A and BRCA2 c.67 + 2T>C, in two patients who appeared to have a strong family history of BC, with an overall prevalence rate of 8.0% in 25 unrelated females diagnosed with familial BC [46]. This evidence concerns the gene BRCA1 and breast cancer.